RxDoctor Payments Data

Mohammad Burney, MD

Orthopaedic Surgery · Rockwall, TXNPI 1932131398

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Smith+Nephew at 42.1% of the total.

$20,378in general payments, 2019–2025

Across 138 payments — averaging $147.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$9K
  • Pylant Medical$3K
  • Zimmer Biomet$3K
  • Stryker$1K
  • Miach Orthopaedics, Inc.$1K
  • Acelrx Pharmaceuticals, Inc.$1K
  • plus $3K from 13 others
$83,431in research payments, 2019–2025

Across 19 payments — averaging $4391.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$45K
  • Episurf Medical, Inc.$25K
  • Medical Device Business Services, Inc.$13K

What the payments were for

  • Consulting fees$1,2006%
  • Speaking & faculty fees$2,61013%
  • Travel & lodging$10,23250%
  • Food & beverage$5,10925%
  • Education$1,2276%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,378 in reported general payments places this provider in the 75th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024
$576,871
Medicare patients
808
Services billed
16,299

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen524$7,418
Celecoxib31$539
Acetaminophen-CodeineAcetaminophen With Codeine41$407
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen30$363
Tramadol Hcl50$250
Diclofenac Sodium35$150
Gabapentin15$123
Ondansetron OdtOndansetron11$117
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav26$93
Meloxicam15$30
Amoxicillin16$22

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Rockwall

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →